Annual Total Liabilities
$11.56 M
+$389.00 K+3.48%
31 March 2024
Summary:
Acasti Pharma annual total liabilities is currently $11.56 million, with the most recent change of +$389.00 thousand (+3.48%) on 31 March 2024. During the last 3 years, it has risen by +$4.76 million (+70.01%). ACST annual total liabilities is now -55.29% below its all-time high of $25.85 million, reached on 31 March 2019.ACST Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$9.21 M
-$1.14 M-11.00%
30 September 2024
Summary:
Acasti Pharma quarterly total liabilities is currently $9.21 million, with the most recent change of -$1.14 million (-11.00%) on 30 September 2024. Over the past year, it has dropped by -$2.25 million (-19.62%). ACST quarterly total liabilities is now -73.29% below its all-time high of $34.49 million, reached on 31 December 2019.ACST Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACST Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.5% | -19.6% |
| 3 y3 years | +70.0% | +64.8% |
| 5 y5 years | -55.3% | -69.1% |
ACST Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.2% | +70.0% | -55.6% | +191.2% |
| 5 y | 5 years | -55.3% | +70.0% | -73.3% | +191.2% |
| alltime | all time | -55.3% | +1107.5% | -73.3% | +862.8% |
Acasti Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.21 M(-11.0%) |
| June 2024 | - | $10.35 M(-10.4%) |
| Mar 2024 | $11.56 M(+3.5%) | $11.56 M(+0.5%) |
| Dec 2023 | - | $11.51 M(+0.3%) |
| Sept 2023 | - | $11.46 M(+27.1%) |
| June 2023 | - | $9.02 M(-19.2%) |
| Mar 2023 | $11.17 M(-45.1%) | $11.17 M(-44.4%) |
| Dec 2022 | - | $20.08 M(-3.2%) |
| Sept 2022 | - | $20.75 M(+1.1%) |
| June 2022 | - | $20.53 M(+0.9%) |
| Mar 2022 | $20.35 M(+199.4%) | $20.35 M(+543.0%) |
| Dec 2021 | - | $3.17 M(-43.4%) |
| Sept 2021 | - | $5.59 M(-20.1%) |
| June 2021 | - | $7.00 M(+2.9%) |
| Mar 2021 | $6.80 M(-31.0%) | $6.80 M(+48.2%) |
| Dec 2020 | - | $4.59 M(-7.5%) |
| Sept 2020 | - | $4.96 M(-45.5%) |
| June 2020 | - | $9.11 M(-7.6%) |
| Mar 2020 | $9.86 M(-61.9%) | $9.86 M(-71.4%) |
| Dec 2019 | - | $34.49 M(+15.6%) |
| Sept 2019 | - | $29.85 M(+12.0%) |
| June 2019 | - | $26.64 M(+3.1%) |
| Mar 2019 | $25.85 M(+126.6%) | $25.85 M(+21.3%) |
| Dec 2018 | - | $21.32 M(-20.7%) |
| Sept 2018 | - | $26.89 M(+82.5%) |
| June 2018 | - | $14.73 M(+29.1%) |
| Mar 2018 | $11.41 M(+305.4%) | $11.41 M(+17.7%) |
| Dec 2017 | - | $9.70 M(+142.9%) |
| Sept 2017 | - | $3.99 M(+46.3%) |
| June 2017 | - | $2.73 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | $2.81 M(+194.0%) | - |
| Nov 2016 | - | $1.35 M(+15.1%) |
| Aug 2016 | - | $1.18 M(-5.0%) |
| May 2016 | - | $1.24 M(+29.4%) |
| Feb 2016 | $957.10 K(-69.9%) | $957.10 K(-32.5%) |
| Nov 2015 | - | $1.42 M(+1.6%) |
| Aug 2015 | - | $1.40 M(-38.5%) |
| May 2015 | - | $2.27 M(-28.7%) |
| Feb 2015 | $3.18 M(-71.3%) | $3.18 M(+0.6%) |
| Nov 2014 | - | $3.16 M(-62.9%) |
| Aug 2014 | - | $8.53 M(+9.6%) |
| May 2014 | - | $7.78 M(-29.9%) |
| Feb 2014 | $11.10 M(+364.6%) | $11.10 M(+136.9%) |
| Nov 2013 | - | $4.69 M(+27.1%) |
| Aug 2013 | - | $3.69 M(+26.5%) |
| May 2013 | - | $2.92 M(+22.0%) |
| Feb 2013 | $2.39 M(+88.6%) | $2.39 M(+15.3%) |
| Nov 2012 | - | $2.07 M(+45.1%) |
| Aug 2012 | - | $1.43 M(-12.2%) |
| May 2012 | - | $1.63 M(+28.4%) |
| Feb 2012 | $1.27 M(-75.8%) | $1.27 M(+10.6%) |
| Nov 2011 | - | $1.15 M(-56.9%) |
| Aug 2011 | - | $2.66 M(+66.5%) |
| May 2011 | - | $1.60 M(-69.5%) |
| Feb 2011 | $5.24 M(+7.3%) | $5.24 M(+16.8%) |
| Nov 2010 | - | $4.49 M(-8.7%) |
| Aug 2010 | - | $4.91 M(+6.0%) |
| May 2010 | - | $4.64 M(-5.1%) |
| Feb 2010 | $4.88 M | $4.88 M(+13.1%) |
| Nov 2009 | - | $4.32 M |
FAQ
- What is Acasti Pharma annual total liabilities?
- What is the all time high annual total liabilities for Acasti Pharma?
- What is Acasti Pharma annual total liabilities year-on-year change?
- What is Acasti Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Acasti Pharma?
- What is Acasti Pharma quarterly total liabilities year-on-year change?
What is Acasti Pharma annual total liabilities?
The current annual total liabilities of ACST is $11.56 M
What is the all time high annual total liabilities for Acasti Pharma?
Acasti Pharma all-time high annual total liabilities is $25.85 M
What is Acasti Pharma annual total liabilities year-on-year change?
Over the past year, ACST annual total liabilities has changed by +$389.00 K (+3.48%)
What is Acasti Pharma quarterly total liabilities?
The current quarterly total liabilities of ACST is $9.21 M
What is the all time high quarterly total liabilities for Acasti Pharma?
Acasti Pharma all-time high quarterly total liabilities is $34.49 M
What is Acasti Pharma quarterly total liabilities year-on-year change?
Over the past year, ACST quarterly total liabilities has changed by -$2.25 M (-19.62%)